Seuraa
Douglas Ziedonis MD, MPH
Douglas Ziedonis MD, MPH
Tuntematon yhteys
Ei vahvistettua sähköpostiosoitetta - Kotisivu
Nimike
Viittaukset
Viittaukset
Vuosi
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
D Ziedonis, B Hitsman, JC Beckham, M Zvolensky, LE Adler, ...
Nicotine & tobacco research, 1691-1715, 2008
8532008
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram
KM Carroll, C Nich, SA Ball, E McCance, BJ Rounsavile
Addiction 93 (5), 713-727, 1998
5311998
Addressing tobacco among individuals with a mental illness or an addiction
JM Williams, D Ziedonis
Addictive behaviors 29 (6), 1067-1083, 2004
4872004
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia
TP George, DM Ziedonis, A Feingold, WT Pepper, CA Satterburg, ...
American journal of psychiatry 157 (11), 1835-1842, 2000
4672000
Nicotine dependence and schizophrenia
DM Ziedonis, TR Kosten, WM Glazer, RJ Frances
Psychiatric Services 45 (3), 204-206, 1994
4671994
Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues
DM Ziedonis, TP George
Schizophrenia bulletin 23 (2), 247-254, 1997
3921997
Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse
RS Schottenfeld, JR Pakes, A Oliveto, D Ziedonis, TR Kosten
Archives of general psychiatry 54 (8), 713-720, 1997
3841997
Buprenorphine versus methadone maintenance for opioid dependence
TR Kosten, R Schottenfeld, D Ziedonis, J Falcioni
The Journal of nervous and mental disease 181 (6), 358-364, 1993
3581993
A multi‐center randomized trial of buprenorphine–naloxone versus clonidine for opioid, detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network
W Ling, L Amass, S Shoptaw, JJ Annon, M Hillhouse, D Babcock, ...
Addiction 100 (8), 1090-1100, 2005
3002005
Effects of clozapine on smoking in chronic schizophrenic outpatients.
TP George, MJ Sernyak, DM Ziedonis, SW Woods
The Journal of clinical psychiatry 56 (8), 344-346, 1995
2971995
Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model
DM Ziedonis, K Trudeau
Schizophrenia Bulletin 23 (2), 229-238, 1997
2641997
Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations
DM Ziedonis, D Smelson, RN Rosenthal, SL Batki, AI Green, RJ Henry, ...
Journal of Psychiatric Practice® 11 (5), 315-339, 2005
2532005
The key elements of dialogic practice in open dialogue: Fidelity criteria
M Olson, J Seikkula, D Ziedonis
The University of Massachusetts Medical School 8, 2017, 2014
2442014
Effectiveness of workshop training for psychosocial addiction treatments: a systematic review
ST Walters, SA Matson, JS Baer, DM Ziedonis
Journal of substance abuse treatment 29 (4), 283-293, 2005
2412005
Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence.
ML Steinberg, DM Ziedonis, JA Krejci, TH Brandon
Journal of consulting and clinical psychology 72 (4), 723, 2004
2362004
Treatment of patients with substance use disorders, American Psychiatric Association
HD Kleber, RD Weiss, RF Anton Jr, TP George, SF Greenfield, TR Kosten, ...
The American journal of psychiatry 164 (4 Suppl), 5-123, 2007
2102007
Enhancing participation in depression care in outpatient perinatal care settings: a systematic review
N Byatt, LL Levin, D Ziedonis, TAM Simas, J Allison
Obstetrics & Gynecology 126 (5), 1048-1058, 2015
1992015
Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment …
D Kalman, S Kim, G DiGirolamo, D Smelson, D Ziedonis
Clinical psychology review 30 (1), 12-24, 2010
1982010
The validity and reliability of a brief measure of cocaine craving
BD Sussner, DA Smelson, S Rodrigues, A Kline, M Losonczy, D Ziedonis
Drug and alcohol dependence 83 (3), 233-237, 2006
1952006
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience
L Amass, W Ling, TE Freese, C Reiber, JJ Annon, AJ Cohen, D McCarty, ...
American Journal on Addictions 13 (sup1), S42-S66, 2004
1952004
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20